Glaukos Ignites Innovation: $80 Million R&D and Manufacturing Hub Breaks Ground in Alabama

Glaukos Corporation, a pioneering force in ophthalmic medical devices, has officially broken ground on a monumental $80 million research, development, and manufacturing facility in Orange Beach, Alabama. This state-of-the-art campus marks a significant expansion for the company, promising to accelerate innovation in the fight against debilitating eye diseases.

The ambitious project is set to become a cornerstone of Glaukos's global operations, consolidating its R&D prowess and manufacturing capabilities under one advanced roof.

The facility is strategically designed to foster groundbreaking advancements in ophthalmology, with a primary focus on developing cutting-edge solutions for glaucoma and retinal diseases. This investment underscores Glaukos's unwavering commitment to improving the lives of patients worldwide through innovative medical technologies.

Expected to be completed by late 2025, the new Alabama facility is not just a technological marvel but also a powerful economic catalyst for the region.

It is projected to create over 150 high-quality jobs, significantly boosting local employment and contributing to the economic vitality of Orange Beach and the broader Baldwin County. The infusion of highly skilled positions, from engineers and scientists to manufacturing specialists, will establish a new hub of medical device expertise in the state.

Company executives, including CEO Thomas Burns, expressed immense enthusiasm for the project during the groundbreaking ceremony.

They highlighted how this expansion is crucial for scaling Glaukos's pipeline of novel therapies and ensuring robust production capacity for its current and future product lines. The facility represents a tangible commitment to long-term growth and leadership in the ophthalmic sector.

Local and state officials also lauded Glaukos's decision to invest in Alabama, emphasizing the collaborative efforts that brought this major development to fruition.

The project is seen as a testament to Alabama's attractive business environment and its growing reputation as a destination for high-tech manufacturing and innovation. This new facility is poised to propel Glaukos to new heights, enabling faster development and broader access to life-changing ophthalmic treatments.